- Report
- July 2023
- 200 Pages
Global
From €4092EUR$4,500USD£3,518GBP
- Report
- July 2023
- 218 Pages
Global
From €4092EUR$4,500USD£3,518GBP
- Report
- January 2023
- 50 Pages
China
From €2728EUR$3,000USD£2,345GBP
- Report
- December 2022
- 83 Pages
Global
From €3183EUR$3,500USD£2,736GBP
- Report
- October 2022
- 270 Pages
Global
From €2898EUR$3,188USD£2,492GBP
€3410EUR$3,750USD£2,932GBP
- Report
- April 2022
- 326 Pages
Global
From €2898EUR$3,188USD£2,492GBP
€3410EUR$3,750USD£2,932GBP
- Report
- November 2021
- 220 Pages
Global
From €2182EUR$2,400USD£1,876GBP
- Report
- January 2021
- 38 Pages
Global
€1198EUR$1,318USD£1,030GBP
- Drug Pipelines
- July 2020
- 1191 Pages
Global
From €2273EUR$2,500USD£1,954GBP
- Drug Pipelines
- December 2019
- 32 Pages
Global
From €3183EUR$3,500USD£2,736GBP
- Report
- August 2019
- 30 Pages
China
From €2001EUR$2,200USD£1,720GBP
- Report
- July 2024
- 103 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- November 2025
- 85 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- September 2024
- 89 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- August 2024
- 93 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- February 2024
- 96 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- September 2022
- 86 Pages
Global
From €3500EUR$4,123USD£3,114GBP

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more